OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015)

被引：2
|
作者：
Gnanasakthy, A. [1 ]
DeMuro, C. [1 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1962
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP101
引用
收藏
页码：A275 / A275
页数：1
相关论文
共 50 条
  • [31] Demographics of clinical trial participants for new molecular entity (NME) oncology drugs and biologics approved by FDA CDER in 2015
    Wright, Hilary
    Elahi, Merina
    Igun, Ayomide
    Soon, Greg
    Chen, Alice
    Pariser, Anne
    Fadiran, Emmanuel
    [J]. CANCER RESEARCH, 2016, 76
  • [32] Canine ocular onchocerciasis: a retrospective review of the diagnosis, treatment, and outcome of 16 cases in New Mexico (2011-2015)
    McLean, Nancy Johnstone
    Newkirk, Kimberly
    Adema, Coenraad M.
    [J]. VETERINARY OPHTHALMOLOGY, 2017, 20 (04) : 349 - 356
  • [33] Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023
    Romanelli, Maria Novella
    Braconi, Laura
    Gabellini, Alessio
    Manetti, Dina
    Marotta, Giambattista
    Teodori, Elisabetta
    [J]. MOLECULES, 2024, 29 (01):
  • [34] Pricing of Regional Airline Services in Australia and New Zealand, 2011-2015
    Gillen, David
    Hazledine, Tim
    [J]. ECONOMIC PAPERS, 2016, 35 (02): : 87 - 98
  • [35] ASSESSMENT OF THE MECHANISMS OF ACTION OF NEW PHARMACEUTICALS APPROVED BY THE FDA BETWEEN 1980 AND 2011
    Kwon, S.
    Araujo-Lama, L.
    Montagne, M.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A249 - A250
  • [36] New agents for cancer treatment approved by FDA in 2011-2014 years
    Fatullayev, Hanifa
    Pasayeva, Leyla
    [J]. ANTI-CANCER DRUGS, 2015, 26 : E26 - E27
  • [37] WANG Tiankai,Sworn in as New President,Underlined Visions (2011-2015)
    Wang Ting
    [J]. China Textile, 2011, (12) : 28 - 30
  • [38] Racial/Ethnic Disparities at the End of an HIV Epidemic: Persons Who Inject Drugs in New York City, 2011-2015
    Des Jarlais, Don C.
    Arasteh, Kamyar
    McKnight, Courtney
    Feelemyer, Jonathan
    Tross, Susan
    Perlman, David
    Friedman, Samuel
    Campbell, Aimee
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2017, 107 (07) : 1157 - 1163
  • [39] Discovery of new epigenetic drugs among FDA-approved drug libraries
    Raynal, Nol J.
    Lee, Justin T.
    Wang, Youjun
    Garriga, Judith
    Malouf, Gabriel
    Dumont, Sarah
    Dettman, Elisha J.
    Gharibyan, Vazganush
    Ahmed, Saira
    Chung, Woonbok
    Childers, Wayne E.
    Abou-Gharbia, Magid
    Henry, Ryan A.
    Andrews, Andrew
    Jelinek, Jaroslav
    Cui, Ying
    Baylin, Stephen B.
    Gill, Donald L.
    Issa, Jean-Pierre J.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [40] TYPES OF ENDPOINTS OF NEW MOLECULAR ENTITIES APPROVED BY THE FDA: THE INCREASING IMPORTANCE OF PATIENT-REPORTED OUTCOMES
    Tan, R.
    McLaughlin, T.
    Duhig, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S140 - S140
12345